1 / 32

Introduction to Clinical Pharmacology Chapter 22- Antidepressant Drugs

Introduction to Clinical Pharmacology Chapter 22- Antidepressant Drugs. Tricyclic Antidespressants: Actions. Increase sensitivity in postsynaptic alpha (a)-adrenergic, serotonin receptors Decreases sensitivity-presynaptic receptor sites Makes neurotransmission activity more effective

umeko
Télécharger la présentation

Introduction to Clinical Pharmacology Chapter 22- Antidepressant Drugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Introduction to Clinical PharmacologyChapter 22-Antidepressant Drugs

  2. Tricyclic Antidespressants: Actions • Increase sensitivity in postsynaptic alpha (a)-adrenergic, serotonin receptors • Decreases sensitivity-presynaptic receptor sites • Makes neurotransmission activity more effective • Inhibits reuptake ofnorepinephrine or serotonin in brain

  3. Tricyclic Antidespressants: Uses • Used to treat: • Depressive episodes • Bipolar disorder; Obsessive-compulsive disorders; Chronic neuropathic pain • Depression-anxiety disorders; Enuresis; Peptic ulcer disease; Sleep apnea; Panic disorder • Bulimia nervosa; Premenstrual symptoms; Dermatological problems; Psychotherapy- severe cases

  4. Tricyclic Antidespressants: Adverse Reaction and Contraindications • Adverse reactions: Sedation, dry mouth, visual disturbances, urinary retention, constipation, photosensitivity • TCS contraindications: Hypersensitivity to drugs, patientson MAOI antidepressants, myocardial infarction, children, lactating mothers; sinequan contraindications- glaucoma, urinary retention

  5. Tricyclic Antidespressants: Precautions • Used cautiously in patients: • Cardiac disease, hepatic and/or renal impairment, hyperthyroid disease • History of seizure activity, narrow angle glaucoma or increased intraocular pressure • Urinary retention, and risk of suicide ideation or behavior

  6. Tricyclic Antidespressants: Interactions

  7. Tricyclic Antidespressants: Interactions (cont’d)

  8. Monoamine Oxidase Inhibitors: Actions and Uses • Actions: Increase in endogenous epinephrine, norepinephrine, dopamine, serotonin in nervous system, increase in neurohormones • Uses: Depressive episodes, psychotherapy, bulimia, night terrors, migraine headaches, seasonal affective disorder, multiple sclerosis

  9. Monoamine Oxidase Inhibitors: Adverse Reaction • Neuromuscular reactions: Orthostatic hypotension, dizziness, vertigo, headache, blurred vision • Gastrointestinal (GI) and genitourinary (GU) system reactions: Constipation, dry mouth, nausea, diarrhea, impotence • Serious adverse reaction: Hypertensive crisis foods containing tyramine

  10. Monoamine Oxidase Inhibitors: Contraindications and Precautions • Contraindications: Elderly patients; hypersensitivity to drugs; pheochromocytoma; liver, kidney or cerebrovascular disease; hypertension; history of headaches; congestive heart failure • Caution: Patients with impaired liver function; history of seizures; parkinsonian symptoms; diabetes; hyperthyroidism; risk of suicidal ideation or behavior

  11. Monoamine Oxidase Inhibitors: Interactions

  12. Monoamine Oxidase Inhibitors: Interactions

  13. Selective Serotonin Reuptake Inhibitors • Actions: Stimulant to reverse depression • Uses: Depressive episodes, bulimia nervosa, panic, premenstrual, post-traumatic stress disorders, anxiety and social phobias, Raynaud’s disease, migraine headaches, diabetic neuropathy, hot flashes • Adverse Reactions • Neuromuscular Reactions: Somnolence, dizziness, headache, insomnia, tremor, weakness

  14. Selective Serotonin Reuptake Inhibitors (cont’d) • Gastrointestinal, genitourinary system reactions: Constipation, dry mouth, nausea, pharyngitis, runny nose, abnormal ejaculation • Contraindications: Hypersensitivity to drugs; pregnancy category C, patients taking cisapride, pimozide or carbamazepine should not take fluvoxamine (prozac) • Precautions: Diabetes mellitus; cardiac disease; impaired liver, or kidney function; risk of suicidal ideation or behavior

  15. Selective Serotonin Reuptake Inhibitors: Interactions

  16. Miscellaneous Antidepressants: Actions and Uses • Affects: Neurotransmission of serotonin, norepinephrine, dopamine • Uses: Depressive episodes, anxiety disorders, neuropathic pain, enhancing weight loss, treating aggressive behaviors, menstrual disorders, cocaine withdrawal, alcohol cravings, fibromyalgia, stress incontinence

  17. Miscellaneous Antidepressants: Adverse Reactions • Neuromuscular reactions: Somnolence, migraine headache, hypotension, dizziness, lightheadedness, vertigo, blurred vision, photosensitivity, insomnia, nervousness or agitation, tremor • Gastrointestinal reactions: Nausea, dry mouth, anorexia, thirst, diarrhea, constipation, bitter taste • Generalized body system reactions

  18. Miscellaneous Antidepressants: Contraindication and Precautions • Contraindications: Hypersensitivity-drugs, maprotiline- seizure disorder, patients on cisapride, pimozide, carbamazepine • Precautions: Cardiac disease; renal and/or hepatic impairment; hyperthyroid disease; risk of suicidal ideation or behavior

  19. Miscellaneous Antidepressants: Interactions

  20. Nursing Process: Assessment • Preadministration assessment: • Obtain medical history • Assess mental status, subjective feelings, slowness to answer questions, monotone speech pattern, sadness or crying • Physical assessment including blood pressure, pulse, respiratory rate, weight, suicidal thoughts • Ask about intent using simple, straight-forward questions

  21. Nursing Process: Assessment • Ongoing assessment: • Monitor vital signs, report change to primary healthcare provider • Observe response to therapy • Document general summary- outward behavior, complaints, problems, compare previous notations, observations

  22. Nursing Process: Nursing Diagnosis and Planning • Self-Care Deficit Syndrome • Disturbed sleep pattern • Nutrition, imbalanced less than bodily requirements • Risk for suicide • Pain

  23. Nursing Process: Nursing Diagnosis and Planning • The expected outcome includes an optimal response to therapy: • Reason for administration of antidepressant • Optimal response to drug therapy • Support patient for adverse drug reactions • Understanding, compliance: Prescribed therapeutic regimen

  24. Nursing Process: Implementation • Promoting an optimal response therapy: • Observe patient for adverse reactions: Notify primary health care provider • Observe: Behavioral changes during initial therapy when dosage increased, decreased • Patientswith depression: Develop nursing care plan, antidepressants, keep patient lying down for 30 minutes

  25. Nursing Process: Implementation • Monitoring and managing patient’s need: • Self-care deficit syndrome • Assist when depression- no physical, or emotional energy to perform self-care activities • Minimize injury risk: Safe environment, assist in changing positions, Assist-activities of daily living, encourage self care, give positive feedback, write behavioral records-periodic intervals, frequency depends– hospital, unit guidelines

  26. Nursing Process: Implementation • Monitoring and managing patient’s need (cont’d): • Disturbed sleep pattern: Promote sleep, wakefulness during day, shut drape at night, opened in day, help patientreorient to day, night time • Imbalanced nutrition, less than bodily requirements: • Monitor fluid dietary intake, monitor weight loss, gain, good oral hygiene, frequent sips of fluids, sugarless gum

  27. Nursing Process: Implementation • Monitoring and managing patient’sneed (cont’d): • Strict dietary control- foods containing tyramine not be eaten for patientson MAOIs, no food from outside • Risk for suicide: Well-supervised environment, wait for therauptic effect; report for: expressions of guilt, hopelessness, helplessness, insomnia, weight loss, direct/indirect threats of suicide, care while swallowing

  28. Nursing Process: Implementation • Monitoring and managing patient’s need (cont’d): • Pain, Acute: • Drugs: Trazodone, priapism-impotence, prolonged, inappropriate penile erection, injection of alpha-adrenergic stimulants, surgical intervention

  29. Nursing Process: Implementation • Educating the patient and family • Managing reactions; patients- continue proper drug regimen, evaluate ability to take responsibility of drugs, explain adverse reactions • Teaching plan: Inform primary health care provider, dentist; dizziness: rise slowly of bed, chair; help changing positions; relieve dry mouth: frequent sips-water, sucking hard candy, chewing gum

  30. Nursing Process: Implementation • Educating the Patientand Family (cont’d) • Teaching plan: Report: Unusual changes, physical effects; avoid prolonged: exposure to sunlight or sunlamps; male patients: Experience prolonged, inappropriate, painful erections-stop drug, notify primary care provider • Evaluation • Therapeutic effect: Achieved • No evidence of injury apparent

  31. Nursing Process: Implementation • Evaluation (cont’d): • Patient: Perform self-care • Adverse reactions: Identified, reported primary health care provider, managed successfully- appropriate nursing interventions • Patient verbalizes: Treatment modalities, importance continued follow-up care • Patient and family demonstrate: Drug regimen

  32. End of Presentation

More Related